Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

Virus-loaded patches successfully kill bacteria in contaminated food

Every year, around 600 million people are struck down by foodborne illnesses. The culprits are often common yet dangerous bacteria, such as E. coli and Salmonella, that thrive in undercooked or ...

India seeks pharma firms partnership to develop indigenous Nipah virus antibody

This move aims to establish an indigenous supply, moving away from current imports and scaling up production to a mandated ...
Le Lézard

Field Effect Earns Coveted Microsoft Virus Initiative (MVI) Membership

Field Effect, a leading innovator in cybersecurity, has officially earned membership into the Microsoft Virus Initiative (MVI)--a distinction reserved for security vendors that meet Microsoft's most ...

Phage G genome: AI analysis maps out world's largest cultivated bacteria-killing virus

Through cutting-edge methods and advanced artificial intelligence analysis, UNC Charlotte researchers leading a ...

This Devastating Virus Has Been Lurking Undetected in U.S. Fields for Nearly 20 Years

Research transforms understanding of disease emergence and identifies new strategies for agricultural virus surveillance in ...

NanoViricides to Present at the PODD 2025 Conference in Boston on October 27

NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...

In Treating Measles Infection, NV-387 Showed Strong Antiviral Activity, and Significantly, Protected Lungs from Damage, Describes NanoViricides

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...
BioSpace

Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award

The company’s technology, a modified herpes simplex virus used to deliver gene therapies, was given the FDA’s new designation ...

A Measles Drug with Strong Activity without Toxicity Can Be Available Now for Emergency Use, Says NanoViricides - NV-387 Broad-Spectrum Antiviral with Activit…

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...

NanoViricides Dual Track Clinical Strategy Explained by a Research Report - Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute ...

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains its dual-track, rapid clinical development strategy for ...
New York Post

First case of US-acquired chikungunya virus confirmed in New York: officials

A person living in New York tested positive for the mosquito-borne chikungunya virus in the first reported transmission within the US in six years, officials said on Tuesday. The chikungunya virus is ...